{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T06:48:02Z","timestamp":1794898082671,"version":"4.9.1"},"reference-count":36,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T00:00:00Z","timestamp":1712707200000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"NIH","award":["1S10OD021644-011A1"],"award-info":[{"award-number":["1S10OD021644-011A1"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2024,1,31]]},"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Essential tremor (ET) is a movement disorder that affects 4%\u20135% of adults &gt;65 years. For patients with medically refractory ET, neurosurgical interventions such as deep brain stimulation (DBS) and unilateral MR-guided focused ultrasound thalamotomy (MRgFUS) are available. In this retrospective cohort study, we examined the demographics of patients with ET who have received MRgFUS and evaluated trends in DBS usage in the USA after the introduction of MRgFUS in 2016.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We used multiple databases to examine the demographics of patients who received DBS and MRgFUS, and trends in DBS. To assess the demographics, we queried the TriNetX database from 2003 to 2022 to identify patients diagnosed with ET and stratify them by DBS or MRgFUS treatment by using Current Procedural Terminology codes. Patient demographics were reported as frequencies and percentages. To examine the trends in DBS for ET, the yearly frequency of DBS procedures done for ET between 2012 and 2019 was extracted from the National Inpatient Sample (NIS) database, and breakpoint analysis was performed. Additionally, the yearly frequency of MRgFUS procedures for ET was obtained from Insightec Exlabate.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Most of the patients (88.69%) in the cohort extracted from TriNetX database self-identified as white, followed by black or African American (2.40%) and Asian (0.52%). A higher percentage of black patients received MRgFUS treatment than DBS (4.10% vs 1.88%). According to the NIS database, from 2012 to 2020, 13\u2009525 patients received DBS for ET.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study provides an overview of the characteristics of patients who undergo DBS or MRgFUS. We found notable differences in sex and race among patients who underwent each treatment type. Additionally, until at least the beginning of 2020, the number of DBS procedures for ET was not negatively affected after the introduction of MRgFUS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2023-000582","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T13:20:25Z","timestamp":1712755225000},"page":"e000582","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Demographics of focused ultrasound thalamotomy for essential tremor and trends in deep brain stimulation surgery after its introduction in the USA"],"prefix":"10.1136","volume":"6","author":[{"given":"Diwas","family":"Gautam","sequence":"first","affiliation":[{"name":"University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Venkatraman","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Horns","sequence":"additional","affiliation":[{"name":"Department of Surgery, Surgical Population Analysis Core, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lexie Zidanyue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Jie","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Duke University School of Medicine, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Kassavetis","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumana","family":"Alshaikh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Moretti","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Shofty","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2718-181X","authenticated-orcid":false,"given":"Shervin","family":"Rahimpour","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah Health, Salt Lake City, Utah, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"2025072811405254000_6.1.e000582.1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l4485","article-title":"Essential tremor: diagnosis and management","volume":"366","author":"Shanker","year":"2019","journal-title":"BMJ"},{"key":"2025072811405254000_6.1.e000582.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1707928"},{"key":"2025072811405254000_6.1.e000582.3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22838"},{"key":"2025072811405254000_6.1.e000582.4","doi-asserted-by":"crossref","DOI":"10.5334\/tohm.632","article-title":"How common is essential tremor? Update on the worldwide prevalence of essential tremor","volume":"11","author":"Louis","year":"2021","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"2025072811405254000_6.1.e000582.5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2147\/NDT.S4795","article-title":"Overview of essential tremor","volume":"6","author":"Zesiewicz","year":"2010","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2025072811405254000_6.1.e000582.6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318236f0fd"},{"key":"2025072811405254000_6.1.e000582.7","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-020-00899-2"},{"key":"2025072811405254000_6.1.e000582.8","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/mds.27700","article-title":"MDS evidence-based review of treatments for essential tremor","volume":"34","author":"Ferreira","year":"2019","journal-title":"Mov Disord"},{"key":"2025072811405254000_6.1.e000582.9","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1992.76.6.0924"},{"key":"2025072811405254000_6.1.e000582.10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000098890","article-title":"Thalamotomy for essential and cerebellar tremor","volume":"65","author":"Shahzadi","year":"1995","journal-title":"Stereotact Funct Neurosurg"},{"key":"2025072811405254000_6.1.e000582.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002173420703"},{"key":"2025072811405254000_6.1.e000582.12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/jnnp.66.6.772","article-title":"Stereotactic thalamotomy in the treatment of essential tremor of the upper extremity: reassessment including a blinded measure of outcome","volume":"66","author":"Zirh","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025072811405254000_6.1.e000582.13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.7.1447"},{"key":"2025072811405254000_6.1.e000582.14","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200101)16:1<140::AID-MDS1025>3.0.CO;2-T"},{"key":"2025072811405254000_6.1.e000582.15","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1212\/WNL.50.3.796","article-title":"Reduction in voice tremor under thalamic stimulation","volume":"50","author":"Carpenter","year":"1998","journal-title":"Neurology"},{"key":"2025072811405254000_6.1.e000582.16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/ana.24892","article-title":"What is the pathway forward for the surgical management of essential tremor","volume":"81","author":"Louis","year":"2017","journal-title":"Ann Neurol"},{"key":"2025072811405254000_6.1.e000582.17","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2005.103.3.0400"},{"key":"2025072811405254000_6.1.e000582.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600159"},{"key":"2025072811405254000_6.1.e000582.19","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25126"},{"key":"2025072811405254000_6.1.e000582.20","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.11.04028","article-title":"The global prevalence of essential tremor, with emphasis on age and sex: a meta-analysis","volume":"11","author":"Song","year":"2021","journal-title":"J Glob Health"},{"key":"2025072811405254000_6.1.e000582.21","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mdc3.13492","article-title":"Therapies, research funding, and racial diversity in essential tremor: a systematic review of the literature","volume":"9","author":"Zesiewicz","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"2025072811405254000_6.1.e000582.22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/ner.12973","article-title":"Gender disparities in deep brain stimulation for Parkinson\u2019s disease","volume":"22","author":"Shpiner","year":"2019","journal-title":"Neuromodulation"},{"key":"2025072811405254000_6.1.e000582.23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/ana.26378","article-title":"Persistent racial disparities in deep brain stimulation for Parkinson\u2019s disease","volume":"92","author":"Cramer","year":"2022","journal-title":"Ann Neurol"},{"key":"2025072811405254000_6.1.e000582.24","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaneurol.2013.5798","article-title":"Disparities in access to deep brain stimulation surgery for Parkinson disease: interaction between African American race and Medicaid use","volume":"71","author":"Chan","year":"2014","journal-title":"JAMA Neurol"},{"key":"2025072811405254000_6.1.e000582.25","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2011.1365"},{"key":"2025072811405254000_6.1.e000582.26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s11060-020-03480-1","article-title":"Geographic disparities in access to glioblastoma treatment based on Hispanic ethnicity in the United States: insights from a national database","volume":"147","author":"Lu","year":"2020","journal-title":"J Neurooncol"},{"key":"2025072811405254000_6.1.e000582.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.11.014"},{"key":"2025072811405254000_6.1.e000582.28","unstructured":"U.S. Census Bureau . Population and housing unit estimates. 2020. Available: https:\/\/www.census.gov\/programs-surveys\/popest.html"},{"key":"2025072811405254000_6.1.e000582.29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.29238","article-title":"Assessment of racial disparities in primary care physician specialty referrals","volume":"4","author":"Landon","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2025072811405254000_6.1.e000582.30","unstructured":"The Michael J . Fox foundation for Parkinson\u2019s research. Currently available deep brain stimulation devices. Available: https:\/\/www.michaeljfox.org\/news\/currently-available-deep-brain-stimulation-devices [Accessed 1 May 2023]."},{"key":"2025072811405254000_6.1.e000582.31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mdc3.13490","article-title":"Benefits and risks of a staged-bilateral VIM versus unilateral VIM DBS for essential tremor","volume":"9","author":"Prakash","year":"2022","journal-title":"Mov Disord Clin Pract"},{"key":"2025072811405254000_6.1.e000582.32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41582-020-00426-z","article-title":"Technology of deep brain stimulation: current status and future directions","volume":"17","author":"Krauss","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"2025072811405254000_6.1.e000582.33","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10072-023-07059-2","article-title":"Long-term safety and efficacy of frameless subthalamic deep brain stimulation in Parkinson\u2019s disease","volume":"45","author":"Genovese","year":"2024","journal-title":"Neurol Sci"},{"key":"2025072811405254000_6.1.e000582.34","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/mds.26997","article-title":"Cost-effectiveness of focused ultrasound, radiosurgery, and DBS for essential tremor","volume":"32","author":"Ravikumar","year":"2017","journal-title":"Mov Disord"},{"key":"2025072811405254000_6.1.e000582.35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073276","article-title":"Clinical outcomes of non-COVID-19 orthopaedic patients admitted during the COVID-19 pandemic: a multi-centre interrupted time series analysis across hospitals in six different countries","volume":"13","author":"Hoogervorst","year":"2023","journal-title":"BMJ Open"},{"key":"2025072811405254000_6.1.e000582.36","unstructured":"Focused Ultrasound Foundation . Focused ultrasound now FDA approved to treat essential tremor patients\u2019 second side. 2023. Available: https:\/\/www.fusfoundation.org\/posts\/focused-ultrasound-now-fda-approved-to-treat-essential-tremor-patients-second-side\/ [Accessed 28 Sep 2023]."}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2023-000582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T18:41:02Z","timestamp":1753728062000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2023-000582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,4,10]]},"published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1136\/bmjno-2023-000582"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2023-000582","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]}}}